Please login to the form below
Hybrigenics appoints Dr Alain Munoz
France-based bio-pharmaceutical company Hybrigenics has appointed Dr Alain Munoz to its board of directors
France-based bio-pharmaceutical company Hybrigenics has appointed Dr Alain Munoz to its board of directors.
Dr Munoz replaces Dr Bernhard Ehmer, president of ImClone Systems, and will chair the clinical advisory board.
He has over 20 years' experience in the pharmaceutical industry at senior management level with the Sanofi Group as R&D vice-president and the French pharmaceutical company Fournier as VP of R&D and business development, subsequently becoming senior VP of the pharmaceutical division.
As well as his position at Hybrigenics, Dr Munoz is also a board member of several biotechnology companies including Novagali Pharma and Zealand Pharma.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
- Roche scores FDA approval for SMA drug risdiplam, now named Evrysdi
- New study identifies drugs that are safe to use in COVID-19 treatment
- Novartis builds its case for novel MS treatment ofatumumab
- Biogen pays Denali $1bn upfront for Parkinson’s disease programme
- Merck enters agreement with Hanmi for investigational NASH drug
- AI: the smart money is on the smart thinking
- US pays $1.5bn for 100 million doses of Moderna’s COVID-19 vaccine
- Vir Biotech plans to start mid-to-late stage study of COVID-19 antibody this month
- Russia becomes first country to approve a COVID-19 vaccine
- Can involving patients in design transform the clinical trial experience?
- Ex-J&J exec Denice Torres joins bluebird bio’s board
- Novavax plans to meet US COVID-19 vaccine demand in 2021
PMHub
SEVEN STONES
Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....
Latest intelligence
- Can involving patients in design transform the clinical trial experience?
- While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...
- Planning your clinical trial? Why you need to engage patients sooner
- It’s highly likely that clinical studies are deterring patients based on decisions made in the early stages, such as during planning and design....
- Patient-centricity in improving patient recruitment advertising
- This blog looks into the importance of concepts and patient centricity in patient recruitment....
Quick links
Infographics
